Hydrogen Nanobots Reduced Radiation Gut Damage in Mice
Efficient active hydrogen delivery for drug-free radiation enteritis therapy in mice
Research hubs: Digestive System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (mouse)
- Authors
- Xianggui Yin, Changfen Bi, Yuanfang Chen, Xueyin Hu, Guangyou Shi, Shuqin Li, Wen Zhang, Longbo Ma, Saijun Fan, Luntao Liu
- Journal
- Nature Communications
- Year
- 2025
- PMID
- 41107261
- Study Type
- Mouse
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
TL;DR
Hydrogen-releasing nanomachines penetrate the gut barrier and relieve radiation enteritis via antioxidant and microbiota-modulating effects.
Key Finding
In a mouse model, hydrogenated molybdenum oxide nanoparticles that release active hydrogen showed superior effectiveness at treating radiation-induced intestinal damage by delivering hydrogen directly to injury sites and promoting tissue repair.
Summary
Radiation therapy for pelvic and abdominal cancers damages the intestines in over 90% of patients, primarily through creating harmful molecules called reactive oxygen and nitrogen species. Researchers developed a drinkable nanoparticle (tiny particle) treatment coated with alginate and chitosan that releases active hydrogen directly into the intestines. In mice with radiation-induced intestinal damage, this treatment penetrated the intestinal mucus barrier, stayed in the intestines longer, and reduced harmful molecules while promoting healing through multiple mechanisms including reducing inflammation and restoring beneficial gut bacteria.
Practical Takeaway
While this early-stage mouse study suggests hydrogen delivery via nanoparticles may help protect intestines from radiation therapy damage, it is not yet tested in humans. The findings are preliminary and much more research—including human clinical trials—would be needed before this approach could be considered for cancer patients. Current radiation enteritis treatments should continue to be discussed with oncologists.
Abstract (excerpt)
Radiation enteritis, affecting over 90% of pelvic/abdominal radiotherapy patients, is primarily caused by radiation-induced reactive oxygen and nitrogen species (RONS). Active hydrogens, with broad-spectrum RONS scavenging ability, show radioprotective potential but face delivery challenges due…